Q3 2022 Holdings
Filed 2022-11-14 | 98 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $193.2M | 4,343,500 | 15.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $173.6M | 491,800 | 13.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $160.2M | 600,000 | 12.6% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $108.6M | 1,389,200 | 8.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $98.3M | 2,538,600 | 7.7% |
| Avantor Inc(AVTR) | COM | 05352A100 | $88.6M | 4,522,600 | 7.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $68.7M | 1,538,600 | 5.4% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $60.4M | 144,800 | 4.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $57.7M | 288,500 | 4.5% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $41.5M | 1,255,374 | 3.3% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $34.3M | 2,684,000 | 2.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $33.6M | 432,400 | 2.6% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $33.5M | 3,172,600 | 2.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $20.3M | 1,357,700 | 1.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $17.8M | 132,000 | 1.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $16.2M | 335,000 | 1.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $15.2M | 794,500 | 1.2% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $15.0M | 1,715,000 | 1.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $12.9M | 742,630 | 1.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $12.9M | 1,303,600 | 1.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $4.6M | 2,000,000 | 0.4% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $325.6K | 1,007,000 | 0.0% |
| Spdr SER TRCall | CALL | 78464A900 | $321.4K | 4,052,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $203.1K | 970,200 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $197.1K | 1,855,700 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $148.5K | 512,800 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $134.3K | 5,586,900 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $119.3K | 1,967,000 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $117.4K | 1,480,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $106.3K | 3,122,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $104.8K | 948,200 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $102.9K | 212,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $97.6K | 2,079,100 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $97.1K | 431,800 | 0.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $94.3K | 207,600 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $91.7K | 1,482,200 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $91.5K | 4,223,100 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $85.0K | 2,051,600 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $76.0K | 1,735,000 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $68.0K | 940,000 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $65.3K | 1,402,500 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $61.0K | 445,500 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $57.6K | 844,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $55.9K | 999,100 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $55.4K | 3,715,400 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $46.6K | 5,414,400 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $45.9K | 4,346,700 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.8K | 2,321,200 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $42.5K | 2,600,000 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $42.4K | 318,300 | 0.0% |